Literature DB >> 34252450

Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.

Norbert H Lameire1, Adeera Levin2, John A Kellum3, Michael Cheung4, Michel Jadoul5, Wolfgang C Winkelmayer6, Paul E Stevens7.   

Abstract

Kidney disease is an important public health problem. Both acute kidney injury (AKI) and chronic kidney disease have been well defined and classified, leading to improved research efforts and subsequent management strategies and recommendations. For those patients with abnormalities in kidney function and/or structure who meet neither the definition of AKI nor chronic kidney disease, there remains a gap in research, care, and guidance. The term acute kidney diseases and disorders, abbreviated to acute kidney disease (AKD), has been introduced as an important construct to address this. To expand and harmonize existing definitions and to ultimately better inform research and clinical care, Kidney Disease: Improving Global Outcomes (KDIGO) organized a consensus workshop. Multiple invitees from around the globe, representing both acute and chronic kidney disease researchers and experts, met virtually to examine existing data, and discuss key concepts related to AKD. Despite some remaining unresolved questions, conference attendees reached general consensus on the definition and classification of AKD, management strategies, and research priorities. AKD is defined by abnormalities of kidney function and/or structure with implications for health and with a duration of ≤3 months. AKD may include AKI, but, more importantly, also includes abnormalities in kidney function that are not as severe as AKI or that develop over a period of >7 days. The cause(s) of AKD should be sought, and classification includes functional and structural parameters. Management of AKD is currently based on empirical considerations. A robust research agenda to enable refinement and validation of definitions and classification systems, and thus testing of interventions and strategies, is proposed.
Copyright © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney disease; acute kidney injury; chronic kidney disease; classification; evaluation; management; staging

Year:  2021        PMID: 34252450     DOI: 10.1016/j.kint.2021.06.028

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  25 in total

1.  Patient outcomes following AKI and AKD: a population-based cohort study.

Authors:  Huan Wang; Emilie Lambourg; Bruce Guthrie; Daniel R Morales; Peter T Donnan; Samira Bell
Journal:  BMC Med       Date:  2022-07-20       Impact factor: 11.150

2.  Risk factors for acute kidney injury after major abdominal surgery in the elderly aged 75 years and above.

Authors:  Jianghua Shen; Yanqi Chu; Chaodong Wang; Suying Yan
Journal:  BMC Nephrol       Date:  2022-06-23       Impact factor: 2.585

Review 3.  Human Stem Cell and Organoid Models to Advance Acute Kidney Injury Diagnostics and Therapeutics.

Authors:  Naomi Pode-Shakked; Prasad Devarajan
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

Review 4.  Overview of Diagnostic Criteria and Epidemiology of Acute Kidney Injury and Acute Kidney Disease in the Critically Ill Patient.

Authors:  Bethany C Birkelo; Neesh Pannu; Edward D Siew
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-15       Impact factor: 10.614

5.  Acute kidney disease predicts chronic kidney disease in pediatric non-kidney solid organ transplant patients.

Authors:  Mital Patel; Anna Heipertz; Emily Joyce; John A Kellum; Christopher Horvat; James E Squires; Shawn C West; Priyanka Priyanka; Dana Y Fuhrman
Journal:  Pediatr Transplant       Date:  2021-10-20

6.  Severe acute kidney disease is associated with worse kidney outcome among acute kidney injury patients.

Authors:  Yih-Giun Cherng; Mai-Szu Wu; Yu-Wei Chen; Mei-Yi Wu; Cheng-Hsien Mao; Yu-Ting Yeh; Tzu-Ting Chen; Chia-Te Liao; Cai-Mei Zheng; Yung-Ho Hsu
Journal:  Sci Rep       Date:  2022-04-20       Impact factor: 4.379

7.  Impact of anemia on in-stent restenosis after percutaneous coronary intervention.

Authors:  Huilin Hu; Shijun Wang; Guanmin Tang; Changlin Zhai; Liang Shen
Journal:  BMC Cardiovasc Disord       Date:  2021-11-19       Impact factor: 2.298

Review 8.  Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence.

Authors:  Jia-Huang Chen; Chih-Kang Chiang
Journal:  Toxins (Basel)       Date:  2021-12-23       Impact factor: 4.546

9.  Characteristics, Influencing Factors, Predictive Scoring System, and Outcomes of the Patients with Nephrotoxicity Associated with Administration of Intravenous Colistin.

Authors:  Pornpen Sangthawan; Alan Frederick Geater; Surarit Naorungroj; Piyarat Nikomrat; Ozioma Forstinus Nwabor; Sarunyou Chusri
Journal:  Antibiotics (Basel)       Date:  2021-12-21

Review 10.  Biological Role, Mechanism of Action and the Importance of Interleukins in Kidney Diseases.

Authors:  Paulina Mertowska; Sebastian Mertowski; Iwona Smarz-Widelska; Ewelina Grywalska
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.